$43.1 million: Amount of savings realized from the 340B program in Fiscal Year 2018.
$87 million: Amount provided as charity care, in-kind health services, volunteer time, and health education training (FY 17).
$365 million: Cost of uncompensated care for Medi-Cal and Medicare patients (FY 18).
About UsUCLA Health is a public academic medical system with hospitals in Los Angeles and Santa Monica and more than 170 outpatient medical practices throughout Southern California. As one of the largest health systems in the state and the largest solid organ transplant center in the country, we serve patients from Southern California and around the world. Ronald Reagan UCLA Medical Center is a Level I Trauma Center, providing local access to the highest level of critical care. With the David Geffen School of Medicine at UCLA, we provide state-of-the-art patient care, train top medical professionals, and support pioneering research and discovery. UCLA Health is eligible to participate in the 340B program because our medical centers provide care to a disproportionate share of low-income Medicare and Medi-Cal (Medicaid) patients.
Benefits of the 340B ProgramSavings realized through participation in the 340B program supports UCLA Health's ability to provide services to under- and uninsured patients, regardless of their ability to pay, and to address health care needs in our community. In addition to providing free and discounted prescription drugs to low-income patients, UCLA Health provides a variety of services to help care for the most vulnerable in our community. Among these services are:
Impact of Scaling Back the 340b Program Scaling back the 340B Program would threaten UCLA Health's capacity to offer the services described above to our patients.